ENP — Entropy Neurodynamics Share News
0.000.00%
Last trade - 00:00- AU$52.13m
- AU$46.56m
- AU$2.06m
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt
Australia's Tryptamine Therapeutic falls on discounted placement
Brief: Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per Share
Brief: Tryptamine Therapeutics Requests Trading Halt For Capital Raising
Brief: Tryptamine Therapeutics Secures A$2.6M In Non-Dilutive Capital To Fast Track Trp-8803 Clinical Development
Brief: Tryptamine Therapeutics Says Herwig Janssen Appointed As Chairman
Brief: Tryptamine Therapeutics Announces A$6 Mln Funding
Brief: Tryptamine Therapeutics Seeks Trading Halt
Brief: Tryptamine Therapeutics Says Hamish George Appointed As CFO
Brief: Tryptamine Therapeutics Seeks Trading Halt
Brief: Exopharm Says Signs Binding Agreement To Acquire Tryp Therapeutics
Brief: Exopharm Says Ian Dixon's Employment As CEO Expected To End In Early 2024
Brief: Exopharm Ltd Says Loss For Year Attributable A$7.1 Mln
Brief: Exopharm Appoints Mark Davies As Chair
Australia's Exopharm hits 10-month high on plans to raise capital
Brief: Exopharm Says In Aggregate Up To A$1.57M (Before Costs) Is Planned To Be Raised